Thomas Burke

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Tyrosine Kinase

Advanced Non Small Cell Lung Cancer

Top Venues

JCO clinical cancer informatics

This page only lists publications with an associated author ORCID identifier.

Publications

Balazs Halmos, Thomas Burke, Chrysostomos Kalyvas, Ralph Insinga, Kristel Vandormael, Andrew Frederickson, Bilal Piperdi
Indirect comparison of pembrolizumab monotherapy versus nivolumab + ipilimumab in first-line metastatic lung cancer. Immunotherapy 14 (5) (2022)
Sarah Sharman Moser, Lior Apter, Ashwini Arunachalam, Thomas Burke, Varda Shalev, Gabriel Chodick, Nava Siegelmann-Danieli
Real-world study of PD-L1 testing patterns and treatment distribution in patients with metastatic non-small-cell lung cancer in Israel. Immunotherapy 13 (10) (2021)
Thomas O Jemielita, Xiaoyun Nicole Li, Thomas Burke, Kai-Li Liaw, Wei Zhou, Cong Chen
Augmenting Real-World Data Through Modeling Key Clinical Trial Eligibility Criteria: An Example of Patients With Non-small-Cell Lung Cancer Treated With Pembrolizumab. JCO clinical cancer informatics 5 (2021)